Clinical Trials in Cleveland

Showing 5781-5800 of 15,050 trials

EPI-743 for Mitochondrial Respiratory Chain Diseases

NCT01370447

This study will evaluate the safety and efficacy of EPI-743 in participants with severe mitochondrial respiratory chain diseases who are considered to be within 90 days of end-of-life care.

Mitochondrial Diseases

PTC Therapeutics

Los Angeles, California, United States • Orange, California, United States • Palo Alto, California, United States +13 more locations

COMPLETEDPhase 2< 1 mile

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

NCT03486834

This study evaluated the safety, tolerability, and efficacy of the cytomegalovirus (CMV) vaccine (V160) administered in a 2-dose or 3-dose regimen to healthy seronegative women 16 to 35 years of age. Participants received blinded V160 on Day 1, Month 2, and Month 6 (3-dose regimen), V160 on Day 1 and Month 6 and placebo at Month 2 (2-dose regimen), or placebo on Day 1, Month 2, and Month 6, and were followed to approximately Month 24. The primary hypothesis of the study was that administration of a 3-dose regimen of V160 will reduce the incidence of primary CMV infection compared to placebo.

Cytomegalovirus (CMV) Infections

Merck Sharp & Dohme LLC2,200 participantsStarted Apr 2018

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Chandler, Arizona, United States +92 more locations

EPI-743 for Mitochondrial Respiratory Chain Diseases

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

Find Trials by Condition in Cleveland

Incorporating Supersaturated Oxygen in Shock

Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma

A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis

Tracking Renal Tumors After Cryoablation Evaluation

Clinical Study of the Solo+ Tympanostomy Tube Device

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Growth and Tolerance of a Partially Hydrolyzed Infant Formula

Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development

A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors